Drug Information Portal - U.S. National Library of Medicine - Quick Access to Quality Drug Information

1 result for Category equals 1815566-23-4
Property	Value
Drug Name:	Ivacaftor mixture with lumacaftor	View Structure
Description:	DailyMed: ORKAMBI is a combination of lumacaftor and ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, indicated for the treatment of cystic fibrosis (CF) in patients age 12 years and older who are homozygous for the F508del mutation in the CFTR gene.

Summary

Detailed Summary

Additional Resources